The DOI matches its Crossref record.
Characterization and superficial transformations on mini-matrices made of interpolymer complexes of chitosan and carboxymethylcellulose during in vitro clarithromycin release
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It (poly B‐(1‐4)‐2‐amino‐2‐deoxy‐d‐glucose) has high antimicrobial activity as a polycationic biopolymer (Gómez‐Burgaz et al., 2009).”
From Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent (2024) · cites this paper as Gómez‐Burgaz et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- Suzuki, 2006, Overview: Helicobacter pylori and extragastric disease, Int. J. Hematol., 84, 291, 10.1532/IJH97.06180 · DOI
- Liu, 2005, In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin, J. Control. Release, 102, 135, 10.1016/j.jconrel.2004.06.022 · DOI
- Nakagawa, 1992, Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin, Chem. Pharm. Bull., 40, 725, 10.1248/cpb.40.725 · DOI
- Ramteke, 2008, Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori, J. Drug. Target., 16, 65, 10.1080/10611860701733278 · DOI
- Patel, 2007, Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres, Curr. Drug Deliv., 4, 41, 10.2174/156720107779314811 · doi:10.2174/156720107779314811
- Berger, 2004, Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications, Eur. J. Pharm. Biopharm., 57, 19, 10.1016/S0939-6411(03)00161-9 · DOI · Paper page
- Just, 1985, vol. 3, 226
- Abdelbary, 2008, Design and in vitro/in vivo evaluation of a novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer, Eur. J. Pharm. Biopharm., 69, 1019, 10.1016/j.ejpb.2008.01.011 · doi:10.1016/j.ejpb.2008.01.011
- de la Torre, 2003, Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid). Study of polymer/polymer and polymer/drug interactions within the network structure, Biomaterials, 24, 1499, 10.1016/S0142-9612(02)00512-4 · DOI · Paper page
- Motwani, 2008, Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterization, Eur. J. Pharm. Biopharm., 69, 513
- Chellat, 2000, Study of biodegradation behaviour of chitosan-xanthan microspheres in simulated physiological media, J. Biomed. Mater. Res., 53, 592, 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P · DOI · Paper page
- Li, 2004, Modulation of combined-release behaviors from a novel “tablets-in-capsule system”, J. Control. Release, 95, 381, 10.1016/j.jconrel.2003.11.023 · DOI
- Koivisto, 2006, Depth profiling of compression-induced disorders and polymorphic on tablet surfaces with grazing incidence X-ray diffraction, Pharm. Res., 23, 813, 10.1007/s11095-006-9785-8 · doi:10.1007/s11095-006-9785-8
- Stedman, 2000, Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors, Aliment. Pharmacol. Ther., 14, 963, 10.1046/j.1365-2036.2000.00788.x · DOI · Paper page
- Kavanagh, 2004, Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices – influence of agitation rate and dissolution medium composition, Int. J. Pharm., 279, 141, 10.1016/j.ijpharm.2004.04.016 · DOI · Paper page
- Davidson, 1986, Relaxation-controlled transport in P(HEMA-co-MMA) copolymers, J. Control. Release, 3, 243, 10.1016/0168-3659(86)90096-9 · DOI
- Debnath, 2004, Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets, Pharm. Res., 21, 149, 10.1023/B:PHAM.0000012163.89163.f8 · doi:10.1023/b:pham.0000012163.89163.f8
- Inoue, 2007, Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation, Int. J. Pharm., 331, 38, 10.1016/j.ijpharm.2006.09.014 · doi:10.1016/j.ijpharm.2006.09.014
- Sohn, 2000, Polymorphism of clarithromycin, Arch. Pharm. Res., 23, 381, 10.1007/BF02975451 · doi:10.1007/bf02975451
- Ghaffari, 2007, Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery, Eur. J. Pharm. Biopharm., 67, 175, 10.1016/j.ejpb.2007.01.013 · DOI · Paper page
- Puttipipatkhachorn, 2001, Drug physical state and drug–polymer interaction on drug release from chitosan matrix films, J. Control. Release, 75, 143, 10.1016/S0168-3659(01)00389-3 · DOI · Paper page
- Aaltonen, 2006, In situ measurement of solvent-mediated phase transformations during dissolution testing, J. Pharm. Sci., 95, 2730, 10.1002/jps.20725 · doi:10.1002/jps.20725
- Caira, 2007, Relationship between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim, J. Pharm. Sci., 96, 996, 10.1002/jps.20934 · DOI
- Othman, 2007, Structural study of polymorphs and solvates of finasteride, J. Pharm. Sci., 96, 1380, 10.1002/jps.20940 · doi:10.1002/jps.20940
- Henry, 2007, Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice, J. Pharm. Sci., 96, 1251, 10.1002/jps.20917 · doi:10.1002/jps.20917
- Lii, 2002, Carboxymethylcellulosegelatin complexes, Carbohyd. Polym., 50, 19, 10.1016/S0144-8617(01)00372-1 · doi:10.1016/s0144-8617(01)00372-1
- Pasparakis, 2006, Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate–chitosan beads, Int. J. Pharm., 323, 34, 10.1016/j.ijpharm.2006.05.054 · DOI · Paper page
- Cho, 2005, Preparation of mucoadhesive chitosan-poly(acrylic acid) microspheres by interpolymer complexation and solvent evaporation method I, Int. J. Kor. Pharm. Sci., 35, 95
- Neto, 2005, Thermal analysis of chitosan based networks, Carbohyd. Polym., 62, 97, 10.1016/j.carbpol.2005.02.022 · DOI · Paper page
- Javadzadeh, 2008, Liquisolid technique as a new approach to sustain propanolol hydrochloride release from tablet matrices, Int. J. Pharm., 362, 102, 10.1016/j.ijpharm.2008.06.022 · doi:10.1016/j.ijpharm.2008.06.022
- Gonzalez Novoa, 2005, Physical solid-state properties and dissolution of sustained-release matrices of polyvinylacetate, Eur. J. Pharm. Biopharm., 59, 343, 10.1016/j.ejpb.2004.07.012 · doi:10.1016/j.ejpb.2004.07.012
- Ma, 2007, Preparation and characterization of sodiummethylcellulose/poly(N-isopropylacrylamide)/clay semi-IPN nanocomposite hydrogels, Eur. Polym. J., 43, 2221, 10.1016/j.eurpolymj.2007.02.026 · doi:10.1016/j.eurpolymj.2007.02.026
- Cooney, 2009, Characterization evaluation of hydrophobically modified chitosan scaffolds: towards design of enzyme immobilized flow-through electrodes, Carbohyd. Polym., 75, 428, 10.1016/j.carbpol.2008.08.008 · doi:10.1016/j.carbpol.2008.08.008
- Mladenovska, 2007, Colon-specific delivery of 5-aminosalicylic acid from chitosan–Ca–alginate microparticles, Int. J. Pharm., 342, 124, 10.1016/j.ijpharm.2007.05.028 · DOI · Paper page
- Lim Soo, 2008, Drug release mechanism of paclitaxel from a chitosan–lipid implant system: effect of swelling degradation and morphology, Eur. J. Pharm. Biopharm., 10.1016/j.ejpb.2007.11.003 · DOI
Cited by
Hajimohammadi, S., Momtaz, H., & Tajbakhsh, E. (2024) · Veterinary Medicine and Science · doi:10.1002/vms3.1440 · Cited by 12
Metadata
- Authors
- Gómez-Burgaz, M., Torrado, G., & Torrado, S.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 73
- Issue
- 1
- Pages
- 130-139
- ISSN
- 0939-6411
- Cited by
- 28
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.